Members Login
 

The WHO Early Release Guideline on ARV and PrEP

were published on September

30th, 2015 and can be

found here:

 Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV

JIAS Special Issue: PrEP Implementation Science: State-of-the-Art and Research Agenda, organized by NEMUS (published July 2015).

 Please visit Nemus´Youtube channell

 

Follow us in Facebook

 

and Twiter

Agenda

Agenda

The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses. CROI 2016 will be held from February 22 to February 25, 2016, in Boston, Massachusetts, at the Hynes Convention Center. Webcasts, abstracts, electronic posters, and other electronic resources from CROI 2016 will be available online via webcast.

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiretroviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance project, and regulatory considerations.

 

The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will be held 8 - 10 June 2016 in Washington DC, USA.

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


Wednesday, 17 February 2016 21:37

21st International AIDS Conference (AIDS 2016)

The International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learnt, and collectively chart a course forward.

The AIDS 2016 conference will be held at the Durban International Convention Centre (ICC) from 18 to 22 July 2016.

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


 

HIVR4P is the world's only scientific meeting dedicated exclusively to the latest research on all forms of biomedical HIV prevention. Through both abstract and non-abstract-driven sessions, HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities that are specific to each modality. We expect this cutting-edge, global conference to attract between 1,200 and 1,500 leaders in HIV prevention research, programs, and policy to Chicago.

Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2016, 17-20 October in Chicago.

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


 

The 19th annual United States Conference on AIDS(USCA), will take place September 10-13, 2015, at the new Washington Marriott Marquis hotel located at 901 Massachusetts Avenue, NW in Washington, DC. For nearly two decades, USCA has sought to increase the strength and diversity of the community-based response to the HIV/AIDS epidemic through education, training, new partnerships, collaboration and networking.

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


 

The International Society for Sexually Transmitted Diseases Research exists to promote research on sexually transmitted diseases and facilitate the timely exchange of information among research investigators. To these ends, ISSTDR sponsors a biennial, interdisciplinary scientific meeting, at venues that historically have alternated between Europe and North America. During the three decades since the Society was founded, the ISSTDR meetings have been the premier scientific conferences that address the entire breadth of research on STD, including HIV infections and the acquired immunodeficiency syndrome, and encompassing microbiology, virology, immunobiology, pathogenesis, and other basic sciences; clinical sciences, social and behavioral sciences, epidemiology, and prevention; and research in health services, public health, and prevention policy.

 

ISSTDR was founded in 1977 and is governed by an international Board of Directors who currently represent 7 countries. The ISSTDR Conference Support Foundation provides support in respect of the conferences of the ISSTDR.

 

The 21st Meeting of the ISSTDR will take place as a joint meeting with IUSTI World at the Brisbane Convention and Exhibition Centre, Australia from September 13 to 16, 2015.

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


Page 1 of 2